FGFR3 F386L - Gene Variant Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene FGFR3
Variant F386L
Impact List missense
Protein Effect unknown
Gene Variant Descriptions FGFR3 F386L lies within the transmembrane domain of the Fgfr3 protein (UniProt.org). F386L has been reported as a polymorphism (PMID: 19377444, PMID: 16877735), but has not been biochemically characterized and therefore, its effect on Fgfr3 protein function is unknown (PubMed, Dec 2024).
Associated Drug Resistance
Category Variants Paths

FGFR3 mutant FGFR3 F386L

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_000142.5
gDNA chr4:g.1804410T>C
cDNA c.1156T>C
Protein p.F386L
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
NM_001354809.1 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
NM_001354810.1 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_047449820.1 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713869 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713869.1 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
NM_001163213.1 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_011513422.1 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
NM_001354809.2 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713873.1 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_011513420.1 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
NM_000142.5 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713872 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_011513420 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
NM_000142 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_011513422.2 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_047449823.1 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713871 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713870 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713873 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713870.1 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_047449821.1 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713873.2 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713868 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
NM_001354810.2 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713868.1 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713869.2 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_047449822.1 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
NM_001163213 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713871.1 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713871.2 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
NM_001163213.2 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
NM_000142.4 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_047449824.1 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_011513422 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_011513420.2 chr4:g.1804410T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713868.2 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38
XM_006713870.2 chr4:g.1804404T>C c.1156T>C p.F386L RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
FGFR3 F386L myeloid neoplasm sensitive Zoligratinib Preclinical Actionable In a preclinical study, Debio 1347 inhibited proliferation of myeloma cell lines harboring FGFR3 F386L in culture (PMID: 25169980). 25169980